SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001570562-21-000059
Filing Date
2021-02-19
Accepted
2021-02-19 09:17:56
Documents
15
Period of Report
2021-02-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eols-20210218.htm   iXBRL 8-K 46996
2 EX-99.1 ex99121921.htm EX-99.1 12228
  Complete submission text file 0001570562-21-000059.txt   212354

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20210218.xsd EX-101.SCH 2430
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eols-20210218_cal.xml EX-101.CAL 718
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eols-20210218_def.xml EX-101.DEF 1655
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20210218_lab.xml EX-101.LAB 24975
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20210218_pre.xml EX-101.PRE 13195
8 EXTRACTED XBRL INSTANCE DOCUMENT eols-20210218_htm.xml XML 11034
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38381 | Film No.: 21652232
SIC: 2834 Pharmaceutical Preparations